Graminex - Products containing Flower Pollen Extract - Usefulness of Cernilton in the treatment of benign prostatic hyperplasia

Products Containing Flower Pollen Extract:

Pollen Aid
Prostanex
Graminex Flower
Pollen Extract

We are GMP
Certified

Usefulness of Cernilton in the treatment of benign prostatic hyperplasia

Int Urol Nephrol 1996; 28(1):49-53

Dutkiewicz S

A total of 89 patients with benign prostatic hyperplasia (BPH) were treated pharmacologically for 4 months: 51 received Cernilton and 38 Tadenan (controls). Significant subjective improvement was found in 78% of the patients in the Cernilton group compared to only 55% of the Tadenan-treated patients. The obstructive and irritative symptoms responded best to the therapy. In the Cernilton-treated patients a significant improvement in the uroflow rate, decrease in residual urine and in prostate volume were found. This study shows that Cernilton is an effective therapy for patients with BPH.